BUY Rainbow Childrens Medicare Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
7 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · same horizon·3 Nov · 4d ago
Rainbow Children’s Medicare Q2: Revenue rises 23%, profit grows 11%
NewsCnbc-Tv18·31 Oct · 6d ago
Rainbow Children's Medicare reported Q2 FY27 revenue growth of 23% year-on-year, with EBITDA and PAT growing by 14% and 11% respectively, driven by healthy patient volumes and network expansion.
BSE · Company Update·31 Oct · 6d ago
Rainbow Children's Medicare reported Q2 FY27 revenue of INR 5,480 million, up 23% YoY, and PAT of INR 839 million, up 11% YoY, driven by operational growth and expansion.
BSE · Company Update·31 Oct · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Rainbow Childrens Medicare
- BUY — Axis Securities3 Nov 2026 · ~1 year · target ₹1,610 · Active
- BUY — Centrum3 Nov 2026 · ~1 year · target ₹1,618 · Active
- BUY — Prabhudas Lilladher3 Nov 2026 · ~1 year · target ₹1,650 · Active
- BUY — Sandeep Jain, Tradeswift12 Oct 2026 · ~2 weeks · target ₹1,340 · SL hit
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹1,550 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

